Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology

OBJECTIVE: Nephrotic syndrome (NS) is a common glomerular disease caused by a variety of causes and is the second most common kidney disease. Guizhi is the key drug of Wulingsan in the treatment of NS. However, the action mechanism remains unclear. In this study, network pharmacology and molecular d...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Dan, Li, Qiang, Du, Guangli, Sun, Jijia, Meng, Guofeng, Chen, Shaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643239/
https://www.ncbi.nlm.nih.gov/pubmed/34873575
http://dx.doi.org/10.1155/2021/8141075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643239/
https://www.ncbi.nlm.nih.gov/pubmed/34873575
http://dx.doi.org/10.1155/2021/8141075

Ejemplares similares